HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Healthcare-Associated Pneumonia, Ventilator Associated Pneumonia

In brief

The use of corticosteroids in patients with severe community pneumonia, bacterial infection which kills lots of patients around the world, reduces the mortality of this infection. However, there are no studies with this type of drug regarding hospital-acquired pneumonia. This is the first multicenter randomized trial to test hydrocortisone plus standard therapy in critical care patients with nosocomial pneumonia. This intervention is inexpensive and may improve the outcome of those patients, besides having an acceptable side effects profile.

Key facts

Study ID
NCT05354778
Run by
Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo
People needed
180
Starts
2022-10-16
Expected to finish
2027-02-01
Last updated by the study team
2025-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.